ARE THE HURDLES TOO HIGH FOR ACCESS TO GENE THERAPIES IN THE UK?

被引：0

作者：

Sideris, E. ^{[1
]}

Holdgate, O. ^{[1
]}

Patel, A. ^{[1
]}

Rouse, P. ^{[1
]}

Guest, S. ^{[1
]}

机构：

[1] Roche Prod Ltd, Welwyn Garden City, Herts, England

来源：

VALUE IN HEALTH | 2023年 / 26卷 / 12期

关键词：

D O I：

暂无

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

HTA24

引用

页码：S324 / S324

页数：1

共 50 条

[31] Gene estimate rises as US and UK discuss freedom of access
David Dickson
Nature, 1999, 401 : 311 - 311
[32] Gene estimate rises as US and UK discuss freedom of access
Dickson, D
NATURE, 1999, 401 (6751) : 311 - 311
[33] A vision too far? mapping the space for a high skills project in the UK
Lloyd, Caroline
Payne, Jonathan
JOURNAL OF EDUCATION AND WORK, 2005, 18 (02) : 165 - 185
[34] ARE UK SHARE PRICES TOO HIGH? FUNDAMENTAL VALUE OR NEW ERA
McMillan, David G.
BULLETIN OF ECONOMIC RESEARCH, 2009, 61 (01) : 1 - 20
[35] REIMBURSEMENT HURDLES FOR HIGH-COST BRAND-ON-BRAND COMBINATIONS AND IMPACT ON PATIENT ACCESS
Leoni, G.
Papadopoulou, K.
VALUE IN HEALTH, 2014, 17 (07) : A451 - A451
[36] PAYING FOR CURES: AN ANALYSIS OF INNOVATIVE ACCESS AGREEMENTS FOR LICENSED GENE THERAPIES
Hogg, L.
Richards, M.
VALUE IN HEALTH, 2019, 22 : S431 - S431
[37] Cell and Gene Therapies - Improving Access and Outcomes for Medicare and Medicaid Beneficiaries
Ross, Joseph S.
NEW ENGLAND JOURNAL OF MEDICINE, 2025,
[38] HURDLES TO REIMBURSEMENT FOR GLP-1 THERAPIES IN WEIGHT MANAGEMENT
Stanley, A.
Nisar, S.
Rowlands, C.
VALUE IN HEALTH, 2024, 27 (12) : S354 - S354
[39] Gene-targeted therapies: Towards equitable development, diagnosis, and access
Gaviglio, Amy M. M.
Skinner, Mark W. W.
Lou, Lily J. J.
Finkel, Richard S. S.
Augustine, Erika F. F.
Goldenberg, Aaron J. J.
AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS, 2023, 193 (01) : 56 - 63
[40] USE OF NEW THERAPIES PRIOR TO AUTHORIZATION: REIMBURSEMENT HURDLES IN GERMANY
Mueller, E.
Neeser, K.
Oelze, I. B.
VALUE IN HEALTH, 2020, 23 : S337 - S338

← 1 2 3 4 5 →